Biosonda S.A. is ainmunopharmaceutical company, focused in the research production and commercialization of hemocyanins, for the development of cancer vaccines, adjuvants and for the production of antibodies to haptens and peptides.
The effectiveness of an immunization protocols not only rely on the immunogenicity of the antigenic preparation. Adjutants and immunostimulants incorporated to vaccines enhance protection to disease in humans and commercial animals. Also, the antibody producing industry requires efficient carriers for the production of antibodies in high yields against small drugs, hormones, peptides for research and diagnostic. Therefore, the development and the search for new adjutants and immunostimulantsis decisive to succeed.